We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,725 hedge funds and large institutions have $233B invested in Johnson & Johnson in 2019 Q3 according to their latest regulatory filings, with 91 funds opening new positions, 1,041 increasing their positions, 1,352 reducing their positions, and 102 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less funds holding

Funds holding: 2,7562,725 (-31)

4.6% less ownership

Funds ownership: 72.98%68.38% (-4.6%)

7% less capital invested

Capital invested by funds: $252B → $233B (-$18.5B)

11% less call options, than puts

Call options by funds: $1.71B | Put options by funds: $1.91B

11% less first-time investments, than exits

New positions opened: 91 | Existing positions closed: 102

23% less repeat investments, than reductions

Existing positions increased: 1,041 | Existing positions reduced: 1,352

24% less funds holding in top 10

Funds holding in top 10: 639485 (-154)

Holders
2,725
Holders Change
-31
Holders Change %
-1.12%
% of All Funds
59.75%
Holding in Top 10
485
Holding in Top 10 Change
-154
Holding in Top 10 Change %
-24.1%
% of All Funds
10.63%
New
91
Increased
1,041
Reduced
1,352
Closed
102
Calls
$1.71B
Puts
$1.91B
Net Calls
-$203M
Net Calls Change
+$4.99M
Name Holding Trade Value Shares
Change
Change in
Stake
BWFA
776
Baltimore-Washington Financial Advisors
Maryland
$10.1M -$339K -2,574 -3%
GIP
777
Greatmark Investment Partners
Georgia
$10.1M +$489K +3,709 +5%
TCM
778
Tufton Capital Management
Maryland
$10.1M -$55.1K -418 -0.5%
BCM
779
Buckhead Capital Management
Georgia
$10M -$40.8K -310 -0.4%
SAM
780
Strategy Asset Managers
California
$10M -$280K -2,125 -3%
BCA
781
Bernzott Capital Advisors
California
$9.98M +$132K +1,000 +1%
WIC
782
Wilkins Investment Counsel
Massachusetts
$9.97M +$125K +950 +1%
ARMC
783
American Research & Management Company
Massachusetts
$9.9M +$119K +905 +1%
CG
784
Colony Group
Massachusetts
$9.85M -$277K -2,099 -3%
RWA
785
Ropes Wealth Advisors
Massachusetts
$9.85M +$129K +976 +1%
CNB
786
Camden National Bank
Maine
$9.84M -$2.37K -18 -0%
PGIM
787
Pacific Global Investment Management
California
$9.81M -$58.1K -441 -0.6%
CA
788
Cetera Advisors
Colorado
$9.76M -$431K -3,269 -4%
PPSG
789
Princeton Portfolio Strategies Group
New Jersey
$9.76M -$200K -1,517 -2%
CAM
790
Claret Asset Management
Quebec, Canada
$9.72M -$249K -1,891 -2%
CC
791
Chicago Capital
Illinois
$9.69M +$86.6K +657 +0.9%
AP
792
Appleton Partners
Massachusetts
$9.69M +$116K +883 +1%
CB
793
Community Bank
New York
$9.68M -$109K -825 -1%
DWM
794
Dorchester Wealth Management
Quebec, Canada
$9.63M -$105K -795 -1%
PP
795
Paloma Partners
Connecticut
$9.62M +$1.94M +14,735 +25%
OAM
796
Oxford Asset Management
United Kingdom
$9.61M -$5.71M -43,348 -37%
UR
797
USCA RIA
Texas
$9.61M +$661K +5,020 +7%
SC
798
Saybrook Capital
North Carolina
$9.56M +$281K +2,130 +3%
ARTA
799
A.R.T. Advisors
New York
$9.56M +$5.57M +42,300 +134%
Cerity Partners
800
Cerity Partners
New York
$9.54M +$984K +7,467 +11%

JNJ Hedge Fund Activity: Q3 2019 in Review

2,725 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2019, worth a combined $233B — down 7.4% from $252B a quarter earlier.

Sellers outnumbered buyers: 102 funds closed out of JNJ and 91 opened new positions — a net loss of 11 holders — while 1,352 trimmed existing stakes and 1,041 added.

The largest buyer was Wellington Management Group, adding an estimated $304M. The largest seller was Phocas Financial Corp, cutting an estimated $16.5B.

  • 2,725 institutional investors held Johnson & Johnson (JNJ) as of Q3 2019, down from 2,756 in Q2 2019.
  • Funds reported $233B of Johnson & Johnson stock for Q3 2019, down 7.4% quarter-over-quarter.
  • 91 funds opened new Johnson & Johnson positions in Q3 2019 and 102 closed out, a net change of -11 holders.
  • The largest Johnson & Johnson buyer in Q3 2019 was Wellington Management Group, an estimated $304M added.
  • The largest Johnson & Johnson seller in Q3 2019 was Phocas Financial Corp, an estimated $16.5B sold.

Based on aggregated 13F filings for Q3 2019.